SCHEMBL31705105

SCHEMBL31705105

COC(=O)c1cncc(C2CCN(C(=O)C3COC3)CC2)n1

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 6/20 0.37
▸ CHRM1 P11229 6/20 0.37
▸ CHRM2 P08172 3/20 0.37
▸ NAMPT P43490 6/20 0.36
▸ DGAT2 Q96PD7 2/20 0.35
▸ CHRM5 P08912 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ CHEK1 O14757 1/20 0.34
▸ PDCD1 Q15116 1/20 0.34
▸ CD274 Q9NZQ7 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31706867 0.85 DGAT2 (0.36) NAMPTDGAT2ALDH1A1POLBCHEK1
Lithium Ion SCHEMBL31705638 0.83 DGAT2 (0.35) CHRM4CHRM1NAMPTDGAT2ALDH1A1
Lithium Ion SCHEMBL31706463 0.83 DGAT2 (0.35) CHRM4CHRM1NAMPTDGAT2ALDH1A1
SCHEMBL31706352 0.80 HRH3 (0.38) DGAT2MEN1KMT2AALDH1A1KDM4E
SCHEMBL31705675 0.80 CNR2 (0.41) ALDH1A1KDM4E
SCHEMBL31706082 0.79 GPR119 (0.48) MEN1KMT2AALDH1A1POLBKDM4E
SCHEMBL31704919 0.78 CHRM4 (0.39) CHRM4CHRM1CHRM2NAMPTCHRM5
SCHEMBL31705599 0.78 HRH3 (0.39) CHRM4CHRM1CHRM2CHRM5MEN1
SCHEMBL31705694 0.78 HRH3 (0.39) CHRM4CHRM1CHRM2CHRM5MEN1
SCHEMBL31705447 0.78 CHRM4 (0.39) CHRM4CHRM1CHRM2NAMPTCHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215110-A1 NEW AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS SOS1 INHIBITORS LES LABORATOIRES SERVIER (FR) 2025-10-16 — — WO disclosed
Send feedback